Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06151236
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-11-21
Brief Title:
Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma
Sponsor:
Organization:
Melanoma Institute Australia